
Since 2015, U.S. taxpayers have allocated nearly $13 billion to international “counternarcotics” activities, including law enforcement, military support and punitive drug policies.
According to a report by Harm Reduction International (HRI) and the Drug Policy Alliance (DPA), this spending has prioritized drug control over evidence-based health responses, often leading to severe human rights abuses and undermining global development goals.